Graham Capital Management »

Lexeo Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $327k 33k 9.93

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Applied Digital Corp Note 2.750% 6/0 (Principal)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Sunrun Note 4.000% 3/0 (Principal)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Rivian Automotive Note 3.625%10/1 (Principal)
Green Plains Note 5.250%11/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
The Realreal Debt 4.000% 2/1 (Principal)
Groupon Note 4.875% 6/3 (Principal)
Amazon (AMZN)
Calumet Put Option (CLMT)
Eos Energy Enterprises Com Cl A (EOSE)

View all positions for Graham Capital Management

Top funds holding Lexeo Therapeutics

Henderson Group
BlackRock
Paradigm Biocapital Advisors
Vestal Point Capital
Frazier Life Sciences Management
Balyasny Asset Management
Vanguard Group
Citadel Advisors
venBio Select Advisor
Affinity Asset Advisors
Woodline Partners
State Street Corporation
Millennium Management
OrbiMed Advisors
Point72 Asset Management

View all funds holding Lexeo Therapeutics